Baseline patient characteristics and their adjusted relationships with device-oriented cardiovascular events during follow-up
| . | All patients (n = 1020) . | Hazard ratio (95% CI) . | P-value . |
|---|---|---|---|
| Age (years)a | 64 (56–71) | 1.01 (0.98–1.03) | 0.847 |
| Female sex (%) | 217 (21.3) | 1.02 (0.57–1.82) | 0.946 |
| Left ventricle ejection fraction (%)a | 56 (50–60) | 0.97 (0.94–0.98) | 0.026 |
| Hypertension (%) | 708 (69.4) | 0.85 (0.48–1.49) | 0.565 |
| Hypercholesterolaemia (%) | 635 (62.3) | 0.96 (0.58–1.59) | 0.868 |
| Smoking (%) | 324 (31.8) | 1.58 (0.88–2.84) | 0.122 |
| Family history of CAD (%) | 336 (32.9) | 0.77 (0.45–1.34) | 0.358 |
| Diabetes mellitus (%) | 232 (22.7) | 2.12 (1.23–3.64) | 0.007 |
| CKD (GFR <60 mL/min/1.73 m2) (%) | 130 (12.7) | 1.56 (0.85–2.86) | 0.153 |
| Multi-vessel disease (%) | 546 (53.5) | 1.19 (0.71–1.99) | 0.512 |
| Prior MI (%) | 223 (21.9) | 0.99 (0.55–1.79) | 0.968 |
| Prior coronary revascularization (%) | 339 (33.2) | 1.82 (1.06–3.18) | 0.036 |
| Acute coronary syndrome (%) | 568 (55.7) | 1.35 (0.81–2.24) | 0.252 |
| STEMI (%) | 258 (25.3) | 1.11 (0.62–1.97) | 0.731 |
| NSTEMI (%) | 142 (13.9) | 2.27 (1.27–4.08) | 0.006 |
| Unstable angina (%) | 168 (16.5) | 0.65 (0.33–1.27) | 0.207 |
| Stable angina (%) | 452 (44.3) | 0.74 (0.48–1.24) | 0.252 |
| . | All patients (n = 1020) . | Hazard ratio (95% CI) . | P-value . |
|---|---|---|---|
| Age (years)a | 64 (56–71) | 1.01 (0.98–1.03) | 0.847 |
| Female sex (%) | 217 (21.3) | 1.02 (0.57–1.82) | 0.946 |
| Left ventricle ejection fraction (%)a | 56 (50–60) | 0.97 (0.94–0.98) | 0.026 |
| Hypertension (%) | 708 (69.4) | 0.85 (0.48–1.49) | 0.565 |
| Hypercholesterolaemia (%) | 635 (62.3) | 0.96 (0.58–1.59) | 0.868 |
| Smoking (%) | 324 (31.8) | 1.58 (0.88–2.84) | 0.122 |
| Family history of CAD (%) | 336 (32.9) | 0.77 (0.45–1.34) | 0.358 |
| Diabetes mellitus (%) | 232 (22.7) | 2.12 (1.23–3.64) | 0.007 |
| CKD (GFR <60 mL/min/1.73 m2) (%) | 130 (12.7) | 1.56 (0.85–2.86) | 0.153 |
| Multi-vessel disease (%) | 546 (53.5) | 1.19 (0.71–1.99) | 0.512 |
| Prior MI (%) | 223 (21.9) | 0.99 (0.55–1.79) | 0.968 |
| Prior coronary revascularization (%) | 339 (33.2) | 1.82 (1.06–3.18) | 0.036 |
| Acute coronary syndrome (%) | 568 (55.7) | 1.35 (0.81–2.24) | 0.252 |
| STEMI (%) | 258 (25.3) | 1.11 (0.62–1.97) | 0.731 |
| NSTEMI (%) | 142 (13.9) | 2.27 (1.27–4.08) | 0.006 |
| Unstable angina (%) | 168 (16.5) | 0.65 (0.33–1.27) | 0.207 |
| Stable angina (%) | 452 (44.3) | 0.74 (0.48–1.24) | 0.252 |
CAD, coronary artery disease; CKD, chronic kidney disease; GFR, glomerular filtration rate; DoCE, device-oriented cardiovascular events; MI, myocardial infarction; NSTEMI, non-ST-segment elevation MI; STEMI, ST-segment elevation MI.
aExpressed as median and interquartile range.
Baseline patient characteristics and their adjusted relationships with device-oriented cardiovascular events during follow-up
| . | All patients (n = 1020) . | Hazard ratio (95% CI) . | P-value . |
|---|---|---|---|
| Age (years)a | 64 (56–71) | 1.01 (0.98–1.03) | 0.847 |
| Female sex (%) | 217 (21.3) | 1.02 (0.57–1.82) | 0.946 |
| Left ventricle ejection fraction (%)a | 56 (50–60) | 0.97 (0.94–0.98) | 0.026 |
| Hypertension (%) | 708 (69.4) | 0.85 (0.48–1.49) | 0.565 |
| Hypercholesterolaemia (%) | 635 (62.3) | 0.96 (0.58–1.59) | 0.868 |
| Smoking (%) | 324 (31.8) | 1.58 (0.88–2.84) | 0.122 |
| Family history of CAD (%) | 336 (32.9) | 0.77 (0.45–1.34) | 0.358 |
| Diabetes mellitus (%) | 232 (22.7) | 2.12 (1.23–3.64) | 0.007 |
| CKD (GFR <60 mL/min/1.73 m2) (%) | 130 (12.7) | 1.56 (0.85–2.86) | 0.153 |
| Multi-vessel disease (%) | 546 (53.5) | 1.19 (0.71–1.99) | 0.512 |
| Prior MI (%) | 223 (21.9) | 0.99 (0.55–1.79) | 0.968 |
| Prior coronary revascularization (%) | 339 (33.2) | 1.82 (1.06–3.18) | 0.036 |
| Acute coronary syndrome (%) | 568 (55.7) | 1.35 (0.81–2.24) | 0.252 |
| STEMI (%) | 258 (25.3) | 1.11 (0.62–1.97) | 0.731 |
| NSTEMI (%) | 142 (13.9) | 2.27 (1.27–4.08) | 0.006 |
| Unstable angina (%) | 168 (16.5) | 0.65 (0.33–1.27) | 0.207 |
| Stable angina (%) | 452 (44.3) | 0.74 (0.48–1.24) | 0.252 |
| . | All patients (n = 1020) . | Hazard ratio (95% CI) . | P-value . |
|---|---|---|---|
| Age (years)a | 64 (56–71) | 1.01 (0.98–1.03) | 0.847 |
| Female sex (%) | 217 (21.3) | 1.02 (0.57–1.82) | 0.946 |
| Left ventricle ejection fraction (%)a | 56 (50–60) | 0.97 (0.94–0.98) | 0.026 |
| Hypertension (%) | 708 (69.4) | 0.85 (0.48–1.49) | 0.565 |
| Hypercholesterolaemia (%) | 635 (62.3) | 0.96 (0.58–1.59) | 0.868 |
| Smoking (%) | 324 (31.8) | 1.58 (0.88–2.84) | 0.122 |
| Family history of CAD (%) | 336 (32.9) | 0.77 (0.45–1.34) | 0.358 |
| Diabetes mellitus (%) | 232 (22.7) | 2.12 (1.23–3.64) | 0.007 |
| CKD (GFR <60 mL/min/1.73 m2) (%) | 130 (12.7) | 1.56 (0.85–2.86) | 0.153 |
| Multi-vessel disease (%) | 546 (53.5) | 1.19 (0.71–1.99) | 0.512 |
| Prior MI (%) | 223 (21.9) | 0.99 (0.55–1.79) | 0.968 |
| Prior coronary revascularization (%) | 339 (33.2) | 1.82 (1.06–3.18) | 0.036 |
| Acute coronary syndrome (%) | 568 (55.7) | 1.35 (0.81–2.24) | 0.252 |
| STEMI (%) | 258 (25.3) | 1.11 (0.62–1.97) | 0.731 |
| NSTEMI (%) | 142 (13.9) | 2.27 (1.27–4.08) | 0.006 |
| Unstable angina (%) | 168 (16.5) | 0.65 (0.33–1.27) | 0.207 |
| Stable angina (%) | 452 (44.3) | 0.74 (0.48–1.24) | 0.252 |
CAD, coronary artery disease; CKD, chronic kidney disease; GFR, glomerular filtration rate; DoCE, device-oriented cardiovascular events; MI, myocardial infarction; NSTEMI, non-ST-segment elevation MI; STEMI, ST-segment elevation MI.
aExpressed as median and interquartile range.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
